Literature DB >> 29164486

Adaptation and Probiotic Potential of Lactobacilli, Isolated from the Oral Cavity and Intestines of Healthy People.

Yulia Chervinets1, Vyacheslav Chervinets2, Boris Shenderov3, Ekaterina Belyaeva2, Andrey Troshin2, Sergey Lebedev2, Valery Danilenko4.   

Abstract

The present study shows that, from 300 Lactobacillus strains isolated from the oral cavity and large intestine of 600 healthy people, only 9 had high antagonistic activity against pathogens and opportunistic pathogens. All antagonistic strains of lactobacilli have been identified by 16S rRNA sequencing and assigned to four species: Lactobacillus fermentum, Lactobacillus rhamnosus, Lactobacillus plantarum, and Lactobacillus casei. In addition, these lactobacilli appeared to be nonpathogenic and had some probiotic potential: the strains produced lactic acid and bacteriocins, showed high sensitivity to broad-spectrum antibiotics, and were capable of forming biofilms in vitro. With the help of PCR and specific primers, the presence of genes for prebacteriocins in L. plantarum (plnEF, plnJ, plnN) and L. rhamnosus (LGG_02380 and LGG_02400) has been revealed. It was found that intestinal strains of lactobacilli were resistant to hydrochloric acid and bile. Lactobacilli isolated from the oral cavity were characterized by a high degree of adhesion, whereas intestinal strains were characterized by average adhesion. Both types of lactobacilli had medium to high rates of auto-aggregation and hydrophobicity and could coaggregate with pathogens and opportunistic pathogens. Additionally, the ability of the lactobacilli strains to produce gasotransmitters, CH4, CO2, C2H6, CO, and NH3, has been revealed.

Entities:  

Keywords:  Acid production; Adhesion; Gasotransmitters; Lactobacilli; Oral cavity; Persistence

Mesh:

Substances:

Year:  2018        PMID: 29164486     DOI: 10.1007/s12602-017-9348-9

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  34 in total

1.  Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Authors:  N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 2.  Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy.

Authors:  Michael Camilleri
Journal:  J Clin Gastroenterol       Date:  2006-03       Impact factor: 3.062

Review 3.  [Bacteriocins: criteria, classification, characteristics, methods of detection].

Authors:  L P Blinkova
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  2003 May-Jun

4.  [Method of studying the adhesive process of microorganisms].

Authors:  V I Brilis; T A Brilene; Kh P Lentsner; A A Lentsner
Journal:  Lab Delo       Date:  1986

5.  [Ability of human oral cavity indigenous lactobacilli to form biofilms].

Authors:  Iu V Chervinets; A M Samoukina; V M Chervinets; E S Mikhaĭlova; D V Lebedev; V M Bondarenko
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  2010 Nov-Dec

Review 6.  The role of probiotics in the management of allergic disease.

Authors:  R J Boyle; M L K Tang
Journal:  Clin Exp Allergy       Date:  2006-05       Impact factor: 5.018

7.  Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients.

Authors:  Joseph Rafter; Michael Bennett; Giovanna Caderni; Yvonne Clune; Roisin Hughes; Pernilla C Karlsson; Annett Klinder; Micheal O'Riordan; Gerald C O'Sullivan; Beatrice Pool-Zobel; Gerhard Rechkemmer; Monika Roller; Ian Rowland; Maddalena Salvadori; Herbert Thijs; Jan Van Loo; Bernhard Watzl; John K Collins
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

8.  Manipulating the gut microbiota to maintain health and treat disease.

Authors:  Karen P Scott; Jean-Michel Antoine; Tore Midtvedt; Saskia van Hemert
Journal:  Microb Ecol Health Dis       Date:  2015-02-02

Review 9.  Probiotics as Complementary Treatment for Metabolic Disorders.

Authors:  Mélanie Le Barz; Fernando F Anhê; Thibaut V Varin; Yves Desjardins; Emile Levy; Denis Roy; Maria C Urdaci; André Marette
Journal:  Diabetes Metab J       Date:  2015-08       Impact factor: 5.376

Review 10.  Bugging inflammation: role of the gut microbiota.

Authors:  Sj Shen; Connie Hy Wong
Journal:  Clin Transl Immunology       Date:  2016-04-15
View more
  4 in total

1.  Metataxonomic analysis of microbiota from Pakistani dromedary camelids milk and characterization of a newly isolated Lactobacillus fermentum strain with probiotic and bio-yogurt starter traits.

Authors:  Kanwal Aziz; Zubair Farooq; Muhammad Tariq; Arsalan Haseeb Zaidi
Journal:  Folia Microbiol (Praha)       Date:  2021-02-10       Impact factor: 2.099

2.  Lactobacillus rhamnosus and Lactobacillus casei Affect Various Stages of Gardnerella Species Biofilm Formation.

Authors:  Yuanhui He; Risu Na; Xiaoxi Niu; Bingbing Xiao; Huixia Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-19       Impact factor: 5.293

3.  Lactobacilli: Legal Regulation and Prospects for New Generation Drugs.

Authors:  R A Yunes; E U Poluektova; T V Belkina; V N Danilenko
Journal:  Appl Biochem Microbiol       Date:  2022-09-22       Impact factor: 1.065

Review 4.  Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic.

Authors:  Zhaoxi Deng; Xin M Luo; Jianxin Liu; Haifeng Wang
Journal:  Front Cell Infect Microbiol       Date:  2020-09-25       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.